Researchers have engineered a novel gene therapy designed to suppress pain directly within the brain, circumventing the addictive dangers associated with opioids. Leveraging artificial intelligence to understand pain processing pathways, they devised a specific ‘off switch’ that replicates the pain-relieving effects of morphine while entirely avoiding its hazardous side effects. Preliminary trials have demonstrated that this therapy provides long-lasting pain alleviation without impairing normal sensory functions. This groundbreaking discovery holds immense promise for the development of safer, non-addictive alternatives for pain management.
By Rupert Blackwood
Investigative journalist based in Sheffield, focusing on technology's impact on society. Rupert specializes in cybercrime's effect on communities, from online fraud targeting elderly residents to cryptocurrency scams. His reporting examines social media manipulation, digital surveillance, and how criminal networks operate in cyberspace. With expertise in computer systems, he connects technical complexity with real-world consequences for ordinary people